Bill Wilson, MD: The GLP-1 Shortage, High Costs, and Limited Access—A Growing Healthcare Crisis
Bill Wilson, MD, discusses why GLP-1 drugs are hard to get and expensive. Patients typically need type 2 diabetes or insulin resistance to qualify. Compounded versions cost $150–$200 monthly, but branded drugs run thousands per month, and compounding access may disappear once FDA shortages end, potentially spiking prices to $2,000 monthly.
Questions this video answers
You have to have type 2 diabetes or some sign of insulin resistance.
About $150–$200 per month.
About $2,000 per month.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet